Nanobiotix S.A (NANO) — Cash Flow-to-Debt Ratio
Nanobiotix S.A (NANO) has a Cash Flow-to-Debt Ratio of -0.15x as of June 2025, meaning its operating cash flow of €-17.41 Million could theoretically repay 0% of its total liabilities (€114.13 Million) in one year. Explore long-term investment intensity of Nanobiotix S.A to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Nanobiotix S.A Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Nanobiotix S.A across 14 annual periods. Also explore Nanobiotix S.A assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Nanobiotix S.A (2011–2024)
Year-by-year debt coverage analysis for Nanobiotix S.A. For market capitalisation and broader financial context, see NANO stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.15x | €-19.55 Million | €133.12 Million | ▼ -12.7% |
| 2023 | -0.13x | €-12.48 Million | €95.74 Million | ▲ +69.5% |
| 2022 | -0.43x | €-37.10 Million | €86.81 Million | ▼ -3.4% |
| 2021 | -0.41x | €-31.00 Million | €74.98 Million | ▲ +6.9% |
| 2020 | -0.44x | €-28.24 Million | €63.56 Million | ▲ +37.8% |
| 2019 | -0.71x | €-41.52 Million | €58.11 Million | ▲ +12.1% |
| 2018 | -0.81x | €-25.98 Million | €31.95 Million | ▲ +47.4% |
| 2017 | -1.55x | €-20.95 Million | €13.54 Million | ▼ -10.0% |
| 2016 | -1.41x | €-18.28 Million | €13.00 Million | ▲ +9.7% |
| 2015 | -1.56x | €-16.82 Million | €10.81 Million | ▼ -22.5% |
| 2014 | -1.27x | €-8.56 Million | €6.74 Million | ▲ +20.8% |
| 2013 | -1.60x | €-6.83 Million | €4.26 Million | ▼ -41.0% |
| 2012 | -1.14x | €-3.79 Million | €3.33 Million | ▲ +53.6% |
| 2011 | -2.45x | €-4.87 Million | €1.99 Million | — |